Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 0.04 is 122% above its 5-year average of -0.18, near the high end of its 5-year range (-1.07–0.09).
37.45% below its 12-month average of 0.06.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 0.03.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 18 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:06:43.074Z. Historical observations retain their original dates. Historical series through 2026-10-05.
EARNINGS PER SHARE (EPS)
0.04
EARNINGS PER SHARE (EPS) AVG TTM
0.06
EARNINGS PER SHARE (EPS) AVG 3Y
0.01
EARNINGS PER SHARE (EPS) AVG 5Y
-0.18
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-37.45%
CURRENT VS 3Y AVG
+508.37%
CURRENT VS 5Y AVG
+121.75%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
GoodRx Holdings, Inc.
Market Cap
$1.16B
Earnings Per Share (EPS)
0.04
TTM Avg
0.06
3Y Avg
0.01
5Y Avg
-0.18
Market Cap
$1.17B
Earnings Per Share (EPS)
N/A
TTM Avg
-2.04
3Y Avg
-2.04
5Y Avg
-2.04
Market Cap
$1.14B
Earnings Per Share (EPS)
-0.99
TTM Avg
-0.32
3Y Avg
-0.47
5Y Avg
-0.45
Market Cap
$1.19B
Earnings Per Share (EPS)
-124.78
TTM Avg
-85.76
3Y Avg
-67.06
5Y Avg
-58.99
Market Cap
$1.12B
Earnings Per Share (EPS)
-3.10
TTM Avg
-1.89
3Y Avg
-1.38
5Y Avg
-1.38
Market Cap
$1.11B
Earnings Per Share (EPS)
1.69
TTM Avg
2.70
3Y Avg
2.53
5Y Avg
1.91
Market Cap
$1.11B
Earnings Per Share (EPS)
-0.66
TTM Avg
-0.08
3Y Avg
-1.22
5Y Avg
-1.11
Market Cap
$1.10B
Earnings Per Share (EPS)
1.79
TTM Avg
1.65
3Y Avg
1.42
5Y Avg
1.09
Market Cap
$1.22B
Earnings Per Share (EPS)
0.18
TTM Avg
0.04
3Y Avg
-0.14
5Y Avg
-0.31
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GoodRx Holdings, Inc. (GDRX) | $1.16B | 0.04 | 0.06 | 0.01 | -0.18 |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.17B | N/A | -2.04 | -2.04 | -2.04 |
| Harrow Health, Inc. (HROW)vs › | $1.14B | -0.99 | -0.32 | -0.47 | -0.45 |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.19B | -124.78 | -85.76 | -67.06 | -58.99 |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.12B | -3.10 | -1.89 | -1.38 | -1.38 |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.11B | 1.69 | 2.70 | 2.53 | 1.91 |
| Castle Biosciences, Inc. (CSTL)vs › | $1.11B | -0.66 | -0.08 | -1.22 | -1.11 |
| IRadimed Corporation (IRMD)vs › | $1.10B | 1.79 | 1.65 | 1.42 | 1.09 |
| Cronos Group Inc. (CRON)vs › | $1.22B | 0.18 | 0.04 | -0.14 | -0.31 |
| MannKind Corporation (MNKD)vs › | $1.22B | -0.14 | 0.06 | -0.09 | -0.17 |
Trailing EPS (TTM)
$0.04
Forward EPS (Est.)
$0.30
P/E Ratio
78.7
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 0.09 |
| 2024-12-31 | 0.04 |
| 2023-12-31 | -0.02 |
| 2022-12-31 | -0.08 |
| 2021-12-31 | -0.06 |
| 2020-12-31 | -1.07 |
| 2018-12-31 | 0.12 |
| 2017-12-31 | 0.02 |
| 2016-12-31 | -0.02 |
